Prestige Consumer Healthcare Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 31.08%

Prestige Consumer Healthcare Inc. EBITDA Margin is 31.08% for the Trailing 12 Months (TTM) ending March 31, 2025, a -6.24% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Prestige Consumer Healthcare Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 33.15%, a 9,755.15% change year over year.
  • Prestige Consumer Healthcare Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 0.34%, a -98.94% change year over year.
  • Prestige Consumer Healthcare Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 31.85%, a -3.98% change year over year.
  • Prestige Consumer Healthcare Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 33.17%, a 1.53% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin